The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 26, 2021
Filed:
Oct. 28, 2016
Applicant:
Affibody Ab, Solna, SE;
Inventors:
Elisabet Wahlberg, Sigtuna, SE;
Elin Gunneriusson, Saltsjöbaden, SE;
Assignee:
AFFIBODY AB, Solna, SE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 14/705 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 38/36 (2006.01); C07K 14/745 (2006.01); A61P 35/00 (2006.01); A61K 47/42 (2017.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70532 (2013.01); A61K 38/16 (2013.01); A61K 38/1709 (2013.01); A61K 38/36 (2013.01); A61K 47/42 (2013.01); A61P 35/00 (2018.01); C07K 14/4747 (2013.01); C07K 14/745 (2013.01); A61K 38/00 (2013.01);
Abstract
The present disclosure relates to a class of engineered polypeptides having a binding affinity for programmed death-ligand 1 (PD-L1), and provides a PD-L1 binding polypeptide comprising the sequence ERNXAAXEIL XLPNLXXXQXWAFIWXLXD. The present disclosure also relates to the use of such a PD-L1 binding polypeptide as a therapeutic, prognostic and/or diagnostic agent.